סינטרדיוס - Sintredius
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | H02AB Glucocorticoids |
|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | פ××× - ORAL |
| צ×רת ××× ×× | ת××ס×, SOLUTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | Sintredius oral solution is indicated for the treatment of:- Rheumatological disorders and connective tissue diseases such as: ⢠rheumatoid arthritis (for primary chronic disease and maintenance therapy), ⢠systemic lupus erythematosus (non-organ threatening disease), ⢠mild-moderate juvenile dermatomyositis.- Severe or debilitating allergic conditions, not treatable in a conventional manner such as: ⢠bronchial asthma in children, ⢠bronchial asthma in adults (for maintenance therapy).- Sarcoidosis in children and for maintenance therapy in adults.- Acquired haemolytic anaemia (autoimmune, for maintenance therapy). |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ס×× ×ר×××ס ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | GENETIC S.P.A., ITALY |
| ×©× ××¢× ×ר×ש×× | KAMADA LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 8/2018. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 24/10/2025 |
השינוי האחרון נעשה בֹ־24 באוקטובר 2025 ב־14:47